Advances in the management of gastric cancer

Indian Journal of Surgery

Volumn 71, Issue 6, 2009, Pages 342-349

  Roy, Manas Kumar ^a   Sadhu, Sagar ^a   Dubey, Sanjay Kumar ^a  

^a Narayana Health   (India)

Author keywords

Adjuvant therapy; Gastric cancer; Surgery

Indexed keywords

EID: 74849125343     PISSN: 09722068     EISSN: 09739793     Source Type: Journal    
DOI: 10.1007/s12262-009-0092-6     Document Type: Review

References (62)

1. National Cancer Registry Programme (ICMR). Population based cancer registry 2004-2005. http://www. pbcrindia. org.
2. Yeole BB (2008) Trends in cancer incidence in esophagus, stomach, colon, rectum and liver in males in India. Asian Pac J Cancer Prev 9(1): 97-100.
3. Shrikhande SV, Shukla PJ, Qureshi S, Siddachari R, Upasani V, Ramadwar M, Kakade AC, Hawaldar R (2006) D2 lymphadenectomy for gastric cancer in Tata Memorial Hospital: Indian data can now be incorporated in future international trials. Dig Surg 23(3): 192-197.
4. National Comprehensive Cancer Network Clinical Pratice Guidelines in Oncology. Gastric Cancer V. 2. 2009. http://www. nccn. org.
5. Jadvar H, Tatlidil R, Garcia AA, Conti PS (2003) Evaluation of recurrent gastric malignancy with [F-18]-FDG positron emission tomography. Clin Radiol 58(3): 215-221.
6. Tsendsuren T, Jun SM, Mian XH (2006) Usefulness of endoscopic ultrasonography in preoperative TNM staging of gastric cancer. World J Gastroenterol 12(1): 43-47.
7. Sarela AI, Lefkowitz R, Brennan MF, Karpeh MS (2006) Selection of patients with gastric adenocarcinoma for laparoscopic staging. Am J Surg 191(1): 134-138.
8. Bentrem D, Wilton A, Mazumdar M, Brennan M, Coit D (2005) The value of peritoneal cytology as a preoperative predictor in patients with gastric carcinoma undergoing a curative resection. Ann Surg Oncol 12(5): 347-353.
9. Bentrem D, Gerdes H, Tang L, Brennan M, Coit D (2007) Clinical correlation of endoscopic ultrasonography with pathologic stage and outcome in patients undergoing curative resection for gastric cancer. Ann Surg Oncol 14(6): 1853-1859.
10. Sarela AI, Miner TJ, Karpeh MS, Coit DG, Jaques DP, Brennan MF (2006) Clinical outcomes with laparoscopic stage M1, unresected gastric adenocarcinoma. Ann Surg 243(2): 189-195.
11. Maruyama K, Okabayashi K, Kinoshita T (1987) Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 11(4): 418-425.
12. Bunt AM, Hermans J, Smit VT, van de Velde CJ, Fleuren GJ, Bruijn JA (1995) Surgical/pathologic-stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries. J Clin Oncol 13(1): 19-25.
13. Sasako M, McCulloch P, Kinoshita T, Maruyama K (1995) New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg 82(3): 346-351.
14. Sue-Ling H (2007) Radical D2 gastrectomy for cancer. The case of D2 resections. Ann R Coll Surg Engl 89(7): 672-674.
15. Gall FP, Hermanek P (1985) New aspects in the surgical treatment of gastric carcinoma - a comparative study of 1636 patients operated on between 1969 and 1982. Eur J Surg Oncol 11: 219-225.
16. Shiu MH, Moore E, Sanders M Huvos A, Freedman B, Goodbold J, Chaiyaphruk S, Wesdorp R, Brennan MF (1987) Influence of the extent of resection on survival after curative treatment of gastric carcinoma. A retrospective multivariate analysis. Arch Surg 122: 1347-1351.
17. Gunderson LL, Sosin H (1982) Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 8(1): 1-11.
18. Ochiai T, Sasako M, Mizuno S, Kinoshita T, Takayama T, Kosuge T, Yamazaki S, Maruyama K (1994) Hepatic resection for metastatic tumours from gastric cancer: analysis of prognostic factors. Br J Surg 81(8): 1175-1178.
19. Cuschieri A, Fayers P, Fielding J, Craven J, Bancewicz J, Joypaul V, Cook P (1996) Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group. Lancet 347(9007): 995-999.
20. Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, Sydes M, Fayers P (1999) Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 79(9-10): 1522-1530.
21. Bonenkamp JJ, Songun I, Hermans J, Sasako M, Welvaart K, Plukker JT, van Elk P, Obertop H, Gouma DJ, Taat CW, et al. (1995) Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 345(8952): 745-748.
22. Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJ, Welvaart K, Songun I, Meyer S, Plukker JT, van Elk P, Obertop H, Gouma DJ, van Lanschot JJ, Taat CW, de Graaf PW, von Meyenfeldt MF, Tilanus H (1999) Dutch Gastric Cancer Group. Extended lymph-node dissection for gastric cancer. N Engl J Med 340(12): 908-914.
23. Hartgrink HH, van de Velde CJ, Putter H, Bonenkamp JJ, Klein Kranenbarg E, Songun I, Welvaart K, van Krieken JH, Meijer S, Plukker JT, van Elk PJ, Obertop H, Gouma DJ, van Lanschot JJ, Taat CW, de Graaf PW, von Meyenfeldt MF, Tilanus H, Sasako M (2004) Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 22(11): 2069-2077.
24. Sue-Ling HM, Johnston D (1995) D1 versus D2 dissection for gastric cancer. Lancet 345(8963): 1515-1516.
25. Parikh D, Johnson M, Chagla L, Lowe D, McCulloch P (1996) D2 gastrectomy: lessons from a prospective audit of the learning curve. Br J Surg 83(11): 1595-1599.
26. Brennan MF (1999) Lymph-node dissection for gastric cancer N Engl J Med 340(12): 956-958.
27. Sasako M (2000) Surgery for gastric cancer. In: Recent Advances in Surgery. 23rd edition, Harcourt Publishers Ltd., Delhi, pp. 11-21.
28. Sano T, Katai H, Sasako M, Maruyama K (2002) One thousand consecutive gastrectomies without operative mortality. Br J Surg 89(1): 123.
29. Mullen JT, Pisters PWT (2007) Subtotal gastrectomy for gastric cancer. In: Mastery of Surgery. 5th edition, Lippincott Williams & Wilkins, Philadelphia, pp. 927-937.
30. Otsuji E, Yamaguchi T, Sawai K, Okamoto K, Takahashi T (1997) End results of simultaneous pancreatectomy, splenectomy and total gastrectomy for patients with gastric carcinoma. Br J Cancer 75(8): 1219-1223.
31. Griffith JP, Sue-Ling HM, Martin I, Dixon MF, McMahon MJ, Axon AT, Johnston D (1995) Preservation of the spleen improves survival after radical surgery for gastric cancer. Gut 36(5): 684-690.
32. Csendes A, Burdiles P, Rojas J, Braghetto I, Diaz JC, Maluenda F (2002) A prospective randomized study comparing D2 total gastrectomy versus D2 total gastrectomy plus splenectomy in 187 patients with gastric carcinoma. Surgery 131(4): 401-407.
33. Weitz J, Jaques DP, Brennan M, Karpeh M (2004) Association of splenectomy with postoperative complications in patients with proximal gastric and gastroesophageal junction cancer. Ann Surg Oncol 11(7): 682-689.
34. McCulloch P, Nita ME, Kazi H, Gama-Rodrigues J (2004) Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach. Cochrane Database Syst Rev 18;(4): CD001964.
35. Degiuli M, Sasako M, Calgaro M, Garino M, Rebecchi F, Mineccia M, Scaglione D, Andreone D, Ponti A, Calvo F Italian Gastric Cancer Study Group (2004) Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial. Eur J Surg Oncol 30(3): 303-308.
36. Siewert JR, Böttcher K, Roder JD, Busch R, Hermanek P, Meyer HJ (1993). Prognostic relevance of systematic lymph node dissection in gastric carcinoma. German Gastric Carcinoma Study Group. Br J Surg 80(8): 1015-1018.
37. Wu CW, Hsiung CA, Lo SS, Hsieh MC, Chen JH, Li AF, Lui WY, Whang-Peng J (2006) Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol 7(4): 309-315.
38. Karpeh MS, Leon L, Klimstra D, Brennan MF (2000) Lymph node staging in gastric cancer: is location more important than Number? An analysis of 1, 038 patients. Ann Surg 232(3): 362-371.
39. Coburn NG (2009) Lymph nodes and gastric cancer. J Surg Oncol 99(4): 199-206.
40. Joyce DJ, McCulloch P (2007) Gastric cancer. In: Textbook of Surgical Oncology. Informa, London, pp. 172-181.
41. Davies J, Johnston D, Sue-Ling H, Young S, May J, Griffith J, Miller G, Martin I (1998) Total or subtotal gastrectomy for gastric carcinoma? A study of quality of life. World J Surg 22(10): 1048-1055.
42. Harrison LE, Karpeh MS, Brennan MF (1998) Total gastrectomy is not necessary for proximal gastric cancer. Surgery 123(2): 127-130.
43. Kim SH, Karpeh MS, Klimstra DS, Leung D, Brennan MF (1999) Effect of microscopic resection line disease on gastric cancer survival. J Gastrointest Surg 3(1): 24-33.
44. Reyes CD, Weber KJ, Gagner M, Divino CM (2001) Laparoscopic vs open gastrectomy. A retrospective review. Surg Endosc 15(9): 928-931.
45. Huscher CG, Mingoli A, Sgarzini G, Sansonetti A, Di Paola M, Recher A, Ponzano C (2005) Laparoscopic versus open subtotal gastrectomy for distal gastric cancer: five-year results of a randomized prospective trial. Ann Surg 241(2): 232-237.
46. Strong VE, Devaud N, Allen PJ, Gonen M, Brennan MF, Coit D (2009) Laparoscopic versus open subtotal gastrectomy for adenocarcinoma: a case-control study. Ann Surg Oncol 16(6): 1507-1513.
47. Hoya Y, Mitsumori N, Yanaga K (2009) The advantages and disadvantages of a Roux-en-Y reconstruction after a distal gastrectomy for gastric cancer. Surg Today 39(8): 647-651.
48. Mari E, Floriani I, Tinazzi A, Buda A, Belfiglio M, Valentini M, Cascinu S, Barni S, Labianca R, Torri V (2000) Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente). Ann Oncol 11(7): 837-843.
49. Wagner AD, Grothe W, Behl S, Kleber G, Grothey A, Haerting J, Fleig WE (2005) Chemotherapy for advanced gastric cancer. Cochrane Database Syst Rev (2): CD004064.
50. Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi Y, Imamura H, Higashino M, Yamamura Y, Kurita A, Arai K; ACTS-GC Group (2007) Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357(18): 1810-1820.
51. Cunningham D, Allum WH, Stenning SP, Thompson JN, van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S, Chua YJ; MAGIC Trial Participants (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355(1): 11-20.
52. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, Haller DG, Ajani JA, Gunderson LL, Jessup JM, Martenson JA (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345(10): 725-730.
53. Mansour JC, Tang L, Shah M, Bentrem D, Klimstra DS, Gonen M, Kelsen DP, Brennan MF, Coit DG (2007) Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer? Ann Surg Oncol 14(12): 3412-3418.
54. Ott K, Weber WA, Lordick F, Becker K, Busch R, Herrmann K, Wieder H, Fink U, Schwaiger M, Siewert JR (2006) Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction. J Clin Oncol 24(29): 4692-4698.
55. House MG, Brennan MF (2008) Neoadjuvant therapy for gastric cancer. Advan Surg 42: 151-168.
56. Catalano V, Graziano F, Santini D, D'Emidio S, Baldelli AM, Rossi D, Vincenzi B, Giordani P, Alessandroni P, Testa E, Tonini G, Catalano G (2008) Second-line chemotherapy for patients with advanced gastric cancer: who may benefit? Br J Cancer 99(9): 1402-1407.
57. Yamamoto S (2001) Stomach cancer incidence in the world Jpn J Clin Oncol 31: 471-477.
58. Huang JQ, Zheng GF, Sumanac K, Irvine EJ, Hunt RH (2003) Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology 125(6): 1636-1644.
59. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ (2001) Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345(11): 784-789.
60. Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, Lai KC, Hu WH, Yuen ST, Leung SY, Fong DY, Ho J, Ching CK, Chen JS (2004) Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 291(2): 187-194.
61. Del Giudice G, Malfertheiner P, Rappuoli R (2009) Development of vaccines against Helicobacter pylori. Expert Rev Vaccines 8(8): 1037-1049.
62. Bielanski W (1999) Epidemiological study on Helicobacter pylori infection and extragastroduodenal disorders in Polish population. J Physiol Pharmacol 50: 723-733.